Cleared Traditional

EPINAUT (K173541) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K173541 · Imedicom Co., Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2018
Decision
282d
Days
Class 2
Risk

K173541 is an FDA 510(k) clearance for the EPINAUT. Classified as Catheter, Conduction, Anesthetic (product code BSO), Class II - Special Controls.

Submitted by Imedicom Co., Ltd. (Gunpo-Si, KR). The FDA issued a Cleared decision on August 24, 2018 after a review of 282 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5120 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Imedicom Co., Ltd. devices

Submission Details

510(k) Number K173541 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 15, 2017
Decision Date August 24, 2018
Days to Decision 282 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
143d slower than avg
Panel avg: 139d · This submission: 282d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BSO Catheter, Conduction, Anesthetic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

LK Consulting Group USA, Inc.
Priscilla Chung

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - BSO Catheter, Conduction, Anesthetic

All 74
Devices cleared under the same product code (BSO) and FDA review panel - the closest regulatory comparables to K173541.
EDEN ControlCath
K241410 · Jmt Co., Ltd. · Feb 2025
Perifix FX Catheter
K231242 · B.Braun Medical, Inc. · Sep 2023
Arrow Non-Stimulating SnapLock Adapter (K-05520-005C)
K230603 · Teleflex Medical · Aug 2023
SubQKath Catheter and Needle Set
K193664 · Hk Surgical · Sep 2020
Percutaneous Introducer
K200624 · Epimed International, Inc. · Apr 2020
C-CAT Anaesthesia Catheter kit
K191470 · Cimpax Aps · Oct 2019